Due to its ability to induce proliferation and activation of neutrophils, G-CSF is clinically used to prevent and treat cancer chemotherapy-induced neutropenia (Crawford et al., 2004; Lyman, 2006). This evidence concerns the gene CSF3 and Decreased total neutrophil count.